Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

NCT: NCT05785832 · COMPLETED

NCT IDNCT05785832
StatusCOMPLETED
Start Date2023-06-01
Completion2024-09-24

Brief Summary

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ+ technology in adults with type 2 diabetes using basal-bolus insulin therapy.

Frequently Asked Questions

What is A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes?

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes is a clinical trial registered under NCT05785832. Current status: COMPLETED.

What is the status of NCT05785832?

The current status of NCT05785832 (A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes) is: COMPLETED.

When did A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes start?

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes started on 2023-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑